Six months after laying off 18% of its workforce, Inovio is sending out more pink slips. This round of redundancies will see 11% of remaining employees heading for the exits as the biotech unveils yet another restructuring.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,